Table 4.
ST2 (ng/mL) | p | ||
---|---|---|---|
E/e'm | ≤8 | 30.67 ± 22.18 | 0.03a |
9–12 | 33.34 ± 27.56 | 0.002b | |
≥13 | 42.16 ± 39.51 | .000c | |
| |||
Diastolic dysfunction | Absent | 27.06 ± 12.97 | .048d |
Grade 1/mild | 30.67 ± 21.06 | .016e | |
Grade 2/moderate | 43.54 ± 17.49 | .008f | |
| |||
Diabetes | Absent | 32.76 ± 20.61 | .002g |
Present | 39.16 ± 40.98 | ||
| |||
Additional CV risk | Moderate | 23.66 ± 15.73 | .020h |
High | 31.58 ± 20.96 | .04i | |
Very high | 40.16 ± 28.03 | .026j |
a E/e'm ≤ 8 versus E/e'm = 9–12; bE/e'm = 9–12 versus E/e'm ≥ 13; cE/e'm ≤ 8 versus E/e'm ≥ 13; dabsent versus grade 1; egrade 1 versus grade 2; fabsent versus grade 2; gabsent versus present; hmoderate versus high; ihigh versus very high; jmoderate versus very high; CV: cardiovascular.